BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8521769)

  • 21. Intracavernous drug delivery system: an alternative to intracavernous injection in the treatment of impotence?
    Stief CG; Wetterauer U; Kulvelis F; Popken G; Staubesand J; Sommerkamp H
    Urol Int; 1990; 45(6):321-5. PubMed ID: 2288047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intracavernous pharmacotherapy for management of erectile dysfunction in spinal cord injury.
    Lloyd LK; Richards JS
    Paraplegia; 1989 Dec; 27(6):457-64. PubMed ID: 2608299
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W; de la Fuente RB; Lycklama à Nijeholt AA; Vermeij P; Zwartendijk J
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intracavernous injections for impotence.
    Med Lett Drugs Ther; 1987 Oct; 29(751):95-6. PubMed ID: 3670212
    [No Abstract]   [Full Text] [Related]  

  • 25. Self intra-cavernous injections as a successful treatment in pure neurogenic impotence.
    Greco E; Balbi PP; Virag R
    Riv Neurol; 1991; 61(1):35-8. PubMed ID: 1857921
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Intracavernous injections of vasoactive drugs. Evaluation of their diagnostic and therapeutic value in 65 cases of erectile impotence].
    Buvat J; Lemaire A; Marcolin G; Dehaene JL; Buvat-Herbaut M
    J Urol (Paris); 1986; 92(2):111-6. PubMed ID: 2876042
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E; Israilov S; Shmueli J; Simon D; Baniel J; Livne P
    Harefuah; 1998 May; 134(9):673-8, 750. PubMed ID: 10909609
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Transdermal therapy of erectile insufficiency].
    Canale D; Cilurzo P; Giorgi PM; Menchini Fabris GF
    Arch Ital Urol Nefrol Androl; 1992 Sep; 64(3):263-6. PubMed ID: 1439854
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new alternative in evaluating and treating impotence in men: direct injections of the corpora cavernosa.
    Nankin HR; Osterman J; Lin T; Snoddy W
    J S C Med Assoc; 1987 Feb; 83(2):55-8. PubMed ID: 3470558
    [No Abstract]   [Full Text] [Related]  

  • 30. The use of vasoactive agents in the treatment of erectile impotence.
    Fried FA
    N C Med J; 1990 Jun; 51(6):295-6. PubMed ID: 2366889
    [No Abstract]   [Full Text] [Related]  

  • 31. [Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
    Chandeck Montesa K; Chen Jiménez J; Tamayo JC; Rodríguez Antolín A; Alvarez González E
    Actas Urol Esp; 1992 Mar; 16(3):208-16. PubMed ID: 1621545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Intracavernous auto-injection therapy with papaverine phentolamine via an auto-injection pen for patients with an erectile dysfunction: similar results achieved in family practice and urology].
    de Boer BJ; Lycklama a Nijeholt AA; Kleinjans HA
    Ned Tijdschr Geneeskd; 2001 Apr; 145(16):783-7. PubMed ID: 11346917
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracavernous self-injection with vasoactive intestinal polypeptide and phentolamine in the management of erectile failure.
    Gerstenberg TC; Metz P; Ottesen B; Fahrenkrug J
    J Urol; 1992 May; 147(5):1277-9. PubMed ID: 1569667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Endocavernous drug infusions revisited].
    Bellorofonte C; Ruoppolo M; Dell'Acqua S; Zaatar C; Ferri PM; Yamak R; Tagliaferri A; Tombolini P
    Arch Ital Urol Nefrol Androl; 1991 Dec; 63(4):475-9. PubMed ID: 1838835
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Information and treatment with intracavernous injections of papaverine and phentolamine.
    Lee M; Sharifi R
    J Urol; 1987 May; 137(5):1008-10. PubMed ID: 3573163
    [No Abstract]   [Full Text] [Related]  

  • 36. The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
    Lin JS; Chang WC; Lui SM
    Proc Natl Sci Counc Repub China B; 1994 Jan; 18(1):12-6. PubMed ID: 8029369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Intracavernous injections for the treatment of erectile dysfunction].
    Siegal YI; Lindner A
    Harefuah; 1991 Nov; 121(10):391-3. PubMed ID: 1752559
    [No Abstract]   [Full Text] [Related]  

  • 38. [Experience in the treatment of erectile impotence by the intracavernous auto-injection of vasoactive substances].
    Ferrière JM; Gaston R; Piechaud T; Le Guillou M
    Ann Urol (Paris); 1988; 22(1):57-9. PubMed ID: 3369847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical treatment of impotence with papaverine and phentolamine intracavernosal injection.
    Dinsmore WW
    Ulster Med J; 1990 Oct; 59(2):174-6. PubMed ID: 2278115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impotence: treatment by autoinjection of vasoactive drugs.
    Williams G
    Br Med J (Clin Res Ed); 1987 Nov; 295(6608):1279. PubMed ID: 3120975
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.